Clinical Trials · NCT05573230
A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 32
- Start date
- Oct 2022
- Locations
- 1 site, Singapore
- Primary endpoint
- Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of LY3502970